Loomis, Sayles & Company’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-417,208
| Closed | -$13.7M | – | 726 |
|
|
2024
Q4 | $13.7M | Sell |
417,208
-195,158
| -32% | -$6.41M | 0.02% | 323 |
|
|
2024
Q3 | $27.2M | Buy |
612,366
+163,503
| +36% | +$7.26M | 0.04% | 215 |
|
|
2024
Q2 | $19.4M | Buy |
+448,863
| New | +$19.4M | 0.03% | 261 |
|
|
2021
Q1 | – | Sell |
-295
| Closed | -$13K | – | 834 |
|
|
2020
Q4 | $13K | Buy |
+295
| New | +$13K | ﹤0.01% | 675 |
|
|
2018
Q4 | – | Sell |
-244,675
| Closed | -$18.9M | – | 838 |
|
|
2018
Q3 | $18.9M | Sell |
244,675
-2,649
| -1% | -$204K | 0.04% | 231 |
|
|
2018
Q2 | $20.8M | Buy |
247,324
+1,711
| +0.7% | +$144K | 0.04% | 237 |
|
|
2018
Q1 | $20.1M | Sell |
245,613
-8,113
| -3% | -$663K | 0.04% | 244 |
|
|
2017
Q4 | $14.5M | Buy |
253,726
+42,128
| +20% | +$2.41M | 0.03% | 350 |
|
|
2017
Q3 | $14.1M | Buy |
+211,598
| New | +$14.1M | 0.03% | 350 |
|